Leptin participates in the regulation of glucocorticoid and growth hormone axes

Journal of Nutritional Biochemistry

Volumn 9, Issue 10, 1998, Pages 553-559

  Heiman, Mark L ^a   Chen, Yanyun ^a   Caro, José F ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Adrenal; Growth hormone; Hypothalamus; Leptin; Neuropeptide Y; Pituitary; Somatostatin

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; LEPTIN; NEUROPEPTIDE Y;

ADIPOSE TISSUE; ADRENAL GLAND; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; REVIEW;

EID: 0032190149     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(98)00050-3     Document Type: Review

References (78)

1. Coleman D.L. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia. 9:1973;294-298.
2. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-431.
3. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;543-546.
4. Campfield L.A., Smith F.J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein Evidence for a peripheral signal linking adiposity and central neural networks . Science. 269:1995;546-549.
5. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:1995;540-543.
6. Slieker L.J., Sloop K.W., Surface P.L., Kriauciunas A., LaQuier F., Manetta J., Bue-Valleskey J., Stephens T.W. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J. Biol. Chem. 271:1996;5301-5304.
7. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P.A., Friedman J.M. Leptin levels in human and rodent measurement of plasma leptin and ob RNA in obese- and weight-reduced subjects . Nat. Med. 1:1995;1155-1161.
8. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L., Caro J. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:1996;292-295.
9. Stephens T.W., Basinski M., Bristow P.K., Bue-Valleskey J.M., Burgett S.G., Craft L., Hale J., Hoffmann J., Hsiung H.M., Kriauciunas A., MacKellar W., Rosteck P.R. Jr, Schoner B., Smith D., Tinsley F.C., Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:1995;530-532.
10. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K.J., Smutko J.S., Mays G.G., Woolf E.A., Monroe C.A., Tepper R.I. Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1995;1263-1271.
11. Chen H., Chariat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breitbart R.E., Duyk G.M., Tepper R.I., Morgenstern J.P. Evidence that the diabetes gene encodes the leptin receptor identification of a mutation in the leptin receptor gene in db/db mice . Cell. 84:1996;491-495.
12. Lee G.-H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., Friedman J.M. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:1996;632-635.
13. Streamson C.C. Jr, Chung W.K., Wu-Peng S., Zhang Y., Liu S.-M., Tartaglia L., Leibel R.L. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 271:1996;994-996.
14. White D.W., Kuropatwinski K.K., Devos R., Baumann H., Tartaglia L.A. Leptin receptor (OB-R) signaling. J. Biol. Chem. 272:1997;4065-4071.
15. Ghilaedi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., Skoda R.C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Aci. USA. 93:1996;6231-6235.
16. Fei H., Okano H.J., Li C., Lee G.-H., Zhao C., Darnell R., Friedman J.M. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. USA. 94:1997;7001-7005.
17. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides. 17:1996;305-311.
18. Golden P.L., Maccagnan T.J., Pardridge W.M. Human blood-brain barrier leptin receptor. J. Clin. Invest. 99:1997;14-18.
19. Caro J.F., Sinha M.K., Kolaczynski J.W., Zhang P.L., Considine R.V. Leptin the tale of an obesity gene . Diabetes. 45:1996;1455-1462.
20. Frederich R.C., Löllmann B., Hamann A., Napolitano-Rosen A., Kahn B.B., Lowell B.B., Flier J.S. Expression of ob mRNA and its encoded protein in rodents impact of nutrition and obesity . J. Clin. Invest. 96:1995;1658-1663.
21. Saladin R., De Vos P., Guerro-Millo M., Leturque A., Girard J., Staels B., Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:1995;527-529.
22. Kolaczynski J.W., Considine R.V., Ohannesian J., Marco C., Opentanova I., Nyce M.R., Myint M., Caro J.F. Responses of leptin to short-term fasting and refeeding in humans. Diabetes. 45:1996;1511-1515.
23. Racette S.B., Coppack S.W., Landt M., Klein S. Leptin production during moderate-intensity aerobic exercise. J. Clin. Endocrinol. Metab. 82:1997;2275-2277.
24. Tuominen J.A., Ebeling P., Laquire F.W., Heiman M.L., Stephens T., Koivisto V.A. Serum leptin concentration and fuel homeostasis in healthy man. Eur. J. Clin. Invest. 27:1997;206-211.
25. Casanueva F.F., Dieguez C., Popovic V., Peino R., Considine R.V., Caro J.F. Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery. Biochem. Mol. Med. 60:1997;116-120.
26. Mantzoros C., Flier J.S., Lesem M.D., Brewerton T.D., Jimerson D.C. Cerebrospinal fluid leptin in anorexia nervosa correlation with nutritional status and potential role in resistance to weight gain . J. Clin. Endocrinol. Metab. 82:1997;1845-1851.
27. Montague C.T., Farooqi S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., O'Rahilly S. Congenitial leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:1997;903-908.
28. Glaum S.R., Hara M., Bindokas V.P., Lee C.C., Polonsky K.S., Bell G.I., Miller R.J. Leptin, the Obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol. Pharmacol. 50:1996;230-235.
29. Schwartz M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., Prunkard D.E., Porte J.D., Woods S.C., Seeley R.J., Weigle D.S. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:1996;531-535.
30. Chronwall B., Dimaggio D., Massari V., Pickel V., Ruggiero D., Donohue T. The anatomy of neuropeptide-Y-containing neurons in the rat brain. Neuroscience. 15:1985;1159-1181.
31. Stanley B.G., Magdalin W., Seirafi A., Thomas W.J., Leibowitz S.F. The perifornical area the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s) . Brain Res. 604:1993;304-317.
32. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology. 133:1993;1753-1758.
33. Wahlestedt C., Skagerberg G., Ekman R., Heilig M., Sundler F., Hakanson R. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res. 417:1987;33-38.
34. Harfstrand A., Eneroth A., Agnati L., Fuxe K. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat relationship to hypothalamic catecholamines . Regul. Pept. 17:1987;167-179.
35. Kalra S.P. Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone-releasing hormone discharge. Endocrine Rev. 14:1993;507-538.
36. Kalra S.P., Kalra P.S. Nutritional infertility the role of the interconnected hypothalamic neuropeptide Y-galanin-opiod network . Front. Neuroendocrinol. 17:1996;371-401.
37. Elmquist J., Ahima R.S., Maratos-Flier E., Flier J.S., Saper C.B. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology. 138:1997;839-842.
38. van Dijk G., Thiele T.E., Donahey J.C.K., Campfield L.A., Smith F.J., Burn P., Bernstein I.L., Woods S.C., Seely R.J. Central infusion of leptin and glp-1 (7-36) amide differentially stimulate c-fos-like immunoreactivity in the rat brain. Am. J. Physiol. 40:1996;R1096-R1100.
39. Fulwiler C.E., Saper C.B. Cholecystokinin-immunoreactive innervation of the ventromedial hypothalamus in the rat possible substrate for autonomic regulation of feeding . Neurosci. Lett. 53:1985;289-296.
40. Saper C.B., Loewy A.D., Swanson L.W., Cowan W.M. Direct hypothalamo-autonomic connections. Brain Res. 117:1976;305-312.
41. Wilding J.P.H., Gilbey S.G., Bailey C.J., Batt R.A.L., Williams G., Ghatei M.A., Bloom S.R. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology. 132:1993;1939-1944.
42. Lechan R.M., Nestler J.L., Jacobson S., Reichlin S. The hypothalamic tuberoinfundibular system of the rat as demonstrated by horseradish peroxidase (HRP) microiontophoresis. Brain Res. 195:1980;13-27.
43. Weigand S.J., Price J.L. The cells of the afferent fibers to the median eminence in the rat. J. Comp. Neurol. 192:1980;1-19.
44. Sawchenko P.E., Swanson L.W. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or the spinal cord in the rat. J. Comp. Neurol. 205:1982;260-272.
45. Heiman M.L., Ahima R.S., Craft L.S., Schoner B., Stephens T.W., Flier J.S. Leptin inhibition of the hypothalamic-pituitary adrenal axis in response to stress. Endocrinology. 138:1997;3859-3863.
46. Schwartz M.W., Seeley R.J., Campfield L.A., Burn P., Baskin D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98:1996;1101-1106.
47. Raber J., Chen S., Mucke L., Feng L. Corticotropin-releasing factor and adrenocorticotropic hormone as potential central mediators of OB effects. J. Biol. Chem. 272:1997;15057-15060.
48. Costa A., Poma A., Martignoni E., Nappi G., Ur E., Grossman A. Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants. Neuroreport. 8:1997;1131-1134.
49. Licinio J., Mantzoros C., Negrao A.B., Cizza G., Wong M.-L., Bongiorno P.B., Chrousos G.P., Karp B., Allen C., Flier J.S., Gold P.W. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat. Med. 3:1997;575-579.
50. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature. 382:1996;250-252.
51. Dyer C.J., Simmons J.M., Matteri R.L., Keisler D.H. Leptin receptor mRNA is expressed in ewe anterior pituitary and adipose tissues and is differentially expressed in hypothalamic regions of well-fed and feed-restricted ewes. Domest. Anim. Endocrinol. 14:1997;119-128.
52. Bornstein S.R., Uhimann K., Haidan A., Ehrhart-Bornstein M., Scherbaum W.A. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland. Diabetes. 46:1997;1235-1238.
53. DeVos P., Saladin R., Auwerx J., Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J. Biol. Chem. 270:1995;15958-15961.
54. Wabitsch M., Jensen P.B., Blum W.F., Christoffersen C.T., Englaro P., Heinze E., Rascher W., Teller W., Tornqvist H., Hauner H. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes. 45:1996;1435-1438.
55. Tsagarakis S., Rees L.H., Besser G.M., Grossman A. Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro. Brain Res. 502:1989;167-170.
56. Corder R., Pralong F., Turnill D., Saudan P., Muller A.F., Gaillard R.C. Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neurons. Life Sci. 43:1988;1879-1886.
57. Sinha Y.N., Salocks C.B., Vanderlaan W.P. Prolactin and growth hormone secretion in chemically induced and genetically obese mice. Endocrinology. 97:1975;1386-1393.
58. Carro E., Senaris R., Considine R.V., Casanueva F.F., Dieguez C. Regulation of in vivo growth hormone secretion by leptin. Endocrinology. 138:1997;2203-2206.
59. Vuagnat B.A.M., Pierroz D.D., Lalaoui M., Pralong F.P., Blum W.F., Aubert M.L. Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat. Neuroendocrinology. 67:1998;291-300.
60. Hartman M.L., Veldhuis J.D., Thorner M.O. Normal control of growth hormone secretion. Horm. Res. 40:1993;37-47.
61. Tannenbaum G.S. Genesis of episodic growth hormone secretion. J. Pediatr. Endocrinol. 6:1993;273-282.
62. Quintela M., Señaris R., Heiman M.L., Casanueva F.F., Dieguez C. Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels. Endocrinology. 138:1997;5641-5643.
63. Chan Y.Y., Steiner R.A., Clifton D.K. Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. Endocrinology. 137:1996;1319-1325.
64. Froesch E.R., Schmid C., Schwander J., Zapf J. Actions of insulin-like growth factor activity. Annu. Rev. Physiol. 47:1985;443-467.
65. D'Ercole A.J., Stiles A.D., Underwood L.E. Tissue concentrations of somatomedin-C Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action . Proc. Natl. Acad. Sci. USA. 81:1984;935-939.
66. Goodyear C.G., De Stephano L., Guyda H.J., Posner B.I. Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture. Endocrinology. 115:1984;1568-1576.
67. Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1981;1279-1281.
68. Tannenbaum G.S., Guyda H.J., Posner B.I. Insulin-like growth factors a role in growth hormone negative feedback and body weight regulation via brain . Science. 220:1983;77-79.
69. Böni-Schnetzler M., Gosteli-Peter M.A., Moritz W., Froesch E.R., Zapf J. Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I. Biochem. Biophys. Res. Commun. 225:1996;296-301.
70. Reul B.A., Ongemba L.N., Pottier A.M., Henquin J.C., Brichard S.M. Insulin and insulin-like growth factor 1 antagonize the stimulation of ob gene expression by dexamethasone in cultured rat adipose tissue. Biochem. J. 324:1997;605-610.
71. Fisker S., Vahl N., Hansen T.B., Jørgensen J.O.L., Hagen C., Ørskov H., Christiansen J.S. Serum leptin is increased in growth hormone-deficient adults relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year . Metabolism. 46:1997;812-817.
72. Florkowski C.M., Collier G.R., Zimmet P.Z., Livesey J.H., Espiner E.A., Donald R.A. Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clin. Endocrinol. 45:1996;769-773.
73. Ketelslegers J.M., Maiter D., Maes M., Underwood L.E., Thissen J.P. Nutritional regulation of insulin-like growth factor-I. Metabolism. 44:1995;50-57.
74. Cahill G.F., Herrera M.G., Morgan A.P., Soeldner J.S., Steinke J., Levy P.L., Reichard G.A., Kipnis D.M. Hormone-fuel interrelationships during fasting. J. Clin. Invest. 45:1966;1751-1767.
75. Ho K.Y., Veldhuis J.D., Johnson M.L., Furlanetto R., Evans W.S., Alberti K.G.M.M., Thorner M.O. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J. Clin. Invest. 81:1988;968-975.
76. Tannenbaum G.S., Rostad O., Brazeau P. Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology. 104:1979;1733-1738.
77. Leidy J.W. Jr, Romano T.M., Millard W.J. Developmental and sex-related changes of the growth hormone axis in lean and obese Zucker rats. Neuroendocrinology. 57:1993;213-223.
78. Finkelstein J.A., Jervois P., Menadue M., Willoughby J.O. Growth hormone and prolactin secretion in genetically obese Zucker rats. Endocrinology. 118:1986;1233-1236.